A new near-infrared photoimmunotherapy biomarker paves the way for targeted cancer treatments

Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment. Using ultrasound to track the microbubbles, they were able to identify areas where cancer therapy had not been fully applied.

Leave A Comment

Your email address will not be published. Required fields are marked *